Acta Med. 2019, 62: 45-51
https://doi.org/10.14712/18059694.2019.104
The Interface Between Psychiatry and Ophthalmology
References
1. CC, Lin CL, Tsai YY, Peng CL, Liao YT, Sung FC. Patients with blepharitis are at elevated risk of anxiety and depression. PLoS One 2013 Dec 30; 8(12): e83335.
<https://doi.org/10.1371/journal.pone.0083335>
<PubMed>
2. C, Qian S, WU P, Qiu C. Anxiety and depression in Chinese patients with glaucoma: Sociodemographic, clinical, and self-reported correlates. J Psychosom Res 2013 Jul; 75(1): 75–82.
<https://doi.org/10.1016/j.jpsychores.2013.03.005>
3. HY, Lin CL, Kao CH. Long-term use of selective serotonin reuptake inhibitors and risk of glaucoma in depression patients. Medicine (Baltimore) 2015 Nov; 94(45): e2041.
<https://doi.org/10.1097/MD.0000000000002041>
<PubMed>
4. R, Weaver MA, Lefebvre C, Davis RM. The association between dry eye disease and depression and anxiety in a large population- based study. Am J Ophthalmol 2015 Mar; 159(3): 470–4.
<https://doi.org/10.1016/j.ajo.2014.11.028>
<PubMed>
5. A, Rogers K, Meuleners L, et al. Depressive symptoms in older adults awaiting cataract surgery. Clin Exp Ophthalmol 2016 Dec; 44(9): 789–96.
<https://doi.org/10.1111/ceo.12800>
6. KH, Chen LJ, Young AL. Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond) 2016 Dec; 30(12): 1558–67.
<https://doi.org/10.1038/eye.2016.186>
<PubMed>
7. A, Samimi SM, Entezari M, Seifi MH, Nazari M, Yaseri M. Peripapillary retinal nerve fiber layer thickness in bipolar disorder. Graefes Arch Clin Exp Ophthalmol 2016 Feb; 254(2): 365–71.
<https://doi.org/10.1007/s00417-015-2981-7>
8. RA, Brenner CA, Hetrick WP, et al. Disturbances of visual motion perception in bipolar disorder. Bipolar Disord 2014 June; 16(4): 354–65.
<https://doi.org/10.1111/bdi.12173>
<PubMed>
9. CPB, Abe RY, Diniz-Filho A, Vaz-de-Lima FB, Paranhos A, Medeiros FA. Ophthalmology Issues in Schizophrenia. Curr Psychiatry Rep 2015 May; 17(5): 28.
<https://doi.org/10.1007/s11920-015-0569-x>
<PubMed>
10. FJ, Cabezon L, Quintanilla MA, et al. Retinal nerve fiber layer thickness measured by optical coherence tomography in patients with schizophrenia: A short report. Eur J Psychiat 2010; 24(4): 227–35.
<https://doi.org/10.4321/S0213-61632010000400005>
11. M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases. Sci Rep 2016; 6: 22480.
<https://doi.org/10.1038/srep22480>
<PubMed>
12. CL, Palmieri MG, Pierantozzi M et al. Optic Nerve Dysfunction in Obstructive Sleep Apnea: An Electrophysiological Study. Sleep 2016; 39(1): 19–23.
<https://doi.org/10.5665/sleep.5308>
<PubMed>
13. T, Cumurcu BE, Ozcan O, Demirel S, Duz C, Porgali E, et al. Social phobia and other psychiatric problems in children with strabismus. Can J Ophthalmol 2011 Jun; 46(3): 267–70.
<https://doi.org/10.1016/j.jcjo.2011.05.017>
14. S, Ozkan B, Gok M, Karakaya I, Kara O, Altintas O, et al. Effect of eye trauma on mental health and quality of life in children and adolescents. Int Ophthalmol 2016 Jul; 37(3): 539–44.
<https://doi.org/10.1007/s10792-016-0301-9>
15. J, Davitt BV, Ultmann M, et al. Brief Report: Incidence of Ophthalmologic Disorders in Children with Autism. J Autism Dev Disord 2013; 43: 1447–51.
<https://doi.org/10.1007/s10803-012-1475-2>
16. K, McCarus C, Collins MLZ, et al. Ocular Manifestations of Autism in Ophthalmology. Strabismus 2013; 21(2): 98–102.
<https://doi.org/10.3109/09273972.2013.786733>
17. CW, Lin CC, Kao CH, Chen HY. Association between glaucoma and the risk of dementia. Medicine (Baltimore) 2016 Feb; 95(7): e2833.
<https://doi.org/10.1097/MD.0000000000002833>
<PubMed>
18. KS, Rennie IG, Mudhar HS. Unilateral conjunctival in situ squamous carcinoma with bilateral conjunctival chlorpromazine-induced secondary melanosis masquerading as in situ and invasive melanoma. Ocul Oncol Pathol 2015 Jun; 1(4): 231–6.
<https://doi.org/10.1159/000375343>
<PubMed>
19. I, Aykan U. Psychotropic drugs and ocular side effects. Turk J Ophthalmol 2014; 44: 144–50.
<https://doi.org/10.4274/tjo.67944>
20. H, Acar M, Ozdel K. Aripiprazole induced acute transient bilateral myopia: a case report. Balkan Med J 2015 Apr; 32(2): 230–2.
<https://doi.org/10.5152/balkanmedj.2015.15292>
<PubMed>
21. C, Parmeggiani F, Semeraro F, Sebastiani A. Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure. CurrNeuropharmacol 2008 Dec; 6(4): 293–310.
22. AM, Bosch MM, Watson SL. Ocular pigmentation associated with clozapine. Med J Aust 2009 Feb 16; 190(4): 210–1.
23. Y, Emoto H, Oishi E, Hikita S, Wakakura M. Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation. Drug Healthc Patient Saf 2011; 3: 9–14.
<https://doi.org/10.2147/DHPS.S20691>
<PubMed>
24. JD, Talwar N, Kang JH, Okereke OI, Wiggs JL, Pasquale LR. Bupropion use and risk of open-angle glaucoma among enrollees in a large U.S. managed care network. PLoS One 2015 Apr 13; 10(4): e0123682.
<https://doi.org/10.1371/journal.pone.0123682>
<PubMed>
25. D, Kurtgoz P. Influence of selective serotonin reuptake inhibitors on ocular surface. Clin Exp Optom 2017; 100(1): 83–6.
<https://doi.org/10.1111/cxo.12415>
26. M, Sano I, Ikeda Y, Fujihara E, Tanito M. Intraoperative floppy-iris syndromeassociatedwithuse of antipsychoticdrugs. Can J Ophthalmol 2016 Aug; 51(4): 294–6.
<https://doi.org/10.1016/j.jcjo.2016.02.008>
27. D, Campbell J. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 2005; 31(4): 664–73.
<https://doi.org/10.1016/j.jcrs.2005.02.027>


